Cargando…

1513. Management of Children with Blood Cultures (BC) Positive for Nonpathogenic Organisms After the Introduction of Polymerase Chain Reaction (PCR) Technology

BACKGROUND: Traditionally, clinicians would wait for the absence of growth in BC for 48 hours to consider a BC negative. A BC with a positive gram stain necessitated a repeat BC and antibiotics prior to final identification. Blood culture identification (BCID) PCR has the potential to shorten this t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Julianne, Barone, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810092/
http://dx.doi.org/10.1093/ofid/ofz360.1377
_version_ 1783462162855886848
author Hughes, Julianne
Barone, Stephen
author_facet Hughes, Julianne
Barone, Stephen
author_sort Hughes, Julianne
collection PubMed
description BACKGROUND: Traditionally, clinicians would wait for the absence of growth in BC for 48 hours to consider a BC negative. A BC with a positive gram stain necessitated a repeat BC and antibiotics prior to final identification. Blood culture identification (BCID) PCR has the potential to shorten this time course, particularly with pathogens that are considered “contaminants.” There is no published data which addresses the clinical significance of more rapidly identifying contaminants. METHODS: This is a retrospective chart review of data collected from children (ages 2 months- 18 years) treated at Cohen Children’s Medical Center, who had a positive BC deemed a contaminant. A 2.5-year period prior to and after implementation of PCR technology was observed (September 2015–November 2018). A contaminant was defined as bacteria that is not considered virulent in an immunocompetent patient. Patients with indwelling catheters, those who have undergone corrective cardiac surgery or are immunocompromised were excluded from analysis. Data collected included length of stay, antibiotic duration and whether a patient received a repeat BC. RESULTS: 136 patients during this time (49% (n = 67) pre-PCR and 51% (n = 69) post-PCR) had positive BC for nonvirulent bacteria. Patients in the pre-PCR period received BC only, while those in the post-PCR period received both BC and PCR, with all BC and PCR results being concordant. The proportion of patients who did not receive antibiotics was greater in the post-PCR group (70%, 48 of 69) compared with the pre-PCR group (45%, 30 of 67), P < 0.01. Of those who received antibiotics, the proportion of patients who received more than 1 dose was significantly lower in the post-PCR group (43%, 9 of 21) compared with the pre-PCR group (73%, 27 of 37), P < 0.025. The proportion of patients who had a repeat BC was significantly lower in the post-PCR group (58%, 40 of 69), compared with the pre-PCR group (82%, 55 of 67), P = 0.0022. The proportion of patients who were asked to return to the emergency department was significantly lower in the post-PCR group (59%, 16 of 27), compared with the pre-PCR group (88%, 23 of 26), P = 0.016. CONCLUSION: With the addition of PCR technology, patients with BC positive for nonpathogenic bacteria have received less antibiotics, less repeat BCs and were less frequently asked to return for evaluation.#8232; DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810092
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68100922019-10-28 1513. Management of Children with Blood Cultures (BC) Positive for Nonpathogenic Organisms After the Introduction of Polymerase Chain Reaction (PCR) Technology Hughes, Julianne Barone, Stephen Open Forum Infect Dis Abstracts BACKGROUND: Traditionally, clinicians would wait for the absence of growth in BC for 48 hours to consider a BC negative. A BC with a positive gram stain necessitated a repeat BC and antibiotics prior to final identification. Blood culture identification (BCID) PCR has the potential to shorten this time course, particularly with pathogens that are considered “contaminants.” There is no published data which addresses the clinical significance of more rapidly identifying contaminants. METHODS: This is a retrospective chart review of data collected from children (ages 2 months- 18 years) treated at Cohen Children’s Medical Center, who had a positive BC deemed a contaminant. A 2.5-year period prior to and after implementation of PCR technology was observed (September 2015–November 2018). A contaminant was defined as bacteria that is not considered virulent in an immunocompetent patient. Patients with indwelling catheters, those who have undergone corrective cardiac surgery or are immunocompromised were excluded from analysis. Data collected included length of stay, antibiotic duration and whether a patient received a repeat BC. RESULTS: 136 patients during this time (49% (n = 67) pre-PCR and 51% (n = 69) post-PCR) had positive BC for nonvirulent bacteria. Patients in the pre-PCR period received BC only, while those in the post-PCR period received both BC and PCR, with all BC and PCR results being concordant. The proportion of patients who did not receive antibiotics was greater in the post-PCR group (70%, 48 of 69) compared with the pre-PCR group (45%, 30 of 67), P < 0.01. Of those who received antibiotics, the proportion of patients who received more than 1 dose was significantly lower in the post-PCR group (43%, 9 of 21) compared with the pre-PCR group (73%, 27 of 37), P < 0.025. The proportion of patients who had a repeat BC was significantly lower in the post-PCR group (58%, 40 of 69), compared with the pre-PCR group (82%, 55 of 67), P = 0.0022. The proportion of patients who were asked to return to the emergency department was significantly lower in the post-PCR group (59%, 16 of 27), compared with the pre-PCR group (88%, 23 of 26), P = 0.016. CONCLUSION: With the addition of PCR technology, patients with BC positive for nonpathogenic bacteria have received less antibiotics, less repeat BCs and were less frequently asked to return for evaluation.#8232; DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810092/ http://dx.doi.org/10.1093/ofid/ofz360.1377 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Hughes, Julianne
Barone, Stephen
1513. Management of Children with Blood Cultures (BC) Positive for Nonpathogenic Organisms After the Introduction of Polymerase Chain Reaction (PCR) Technology
title 1513. Management of Children with Blood Cultures (BC) Positive for Nonpathogenic Organisms After the Introduction of Polymerase Chain Reaction (PCR) Technology
title_full 1513. Management of Children with Blood Cultures (BC) Positive for Nonpathogenic Organisms After the Introduction of Polymerase Chain Reaction (PCR) Technology
title_fullStr 1513. Management of Children with Blood Cultures (BC) Positive for Nonpathogenic Organisms After the Introduction of Polymerase Chain Reaction (PCR) Technology
title_full_unstemmed 1513. Management of Children with Blood Cultures (BC) Positive for Nonpathogenic Organisms After the Introduction of Polymerase Chain Reaction (PCR) Technology
title_short 1513. Management of Children with Blood Cultures (BC) Positive for Nonpathogenic Organisms After the Introduction of Polymerase Chain Reaction (PCR) Technology
title_sort 1513. management of children with blood cultures (bc) positive for nonpathogenic organisms after the introduction of polymerase chain reaction (pcr) technology
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810092/
http://dx.doi.org/10.1093/ofid/ofz360.1377
work_keys_str_mv AT hughesjulianne 1513managementofchildrenwithbloodculturesbcpositivefornonpathogenicorganismsaftertheintroductionofpolymerasechainreactionpcrtechnology
AT baronestephen 1513managementofchildrenwithbloodculturesbcpositivefornonpathogenicorganismsaftertheintroductionofpolymerasechainreactionpcrtechnology